Could a constipation drug slow cancer growth? new trial tests axelopran
NCT ID NCT07354919
First seen Jan 30, 2026 · Last updated May 12, 2026 · Updated 14 times
Summary
This study tests if axelopran, a drug typically used for opioid-induced constipation, can help slow tumor growth in people with advanced breast, lung, pancreas, or prostate cancer. About 34 adults whose cancer has worsened after standard treatment will take axelopran capsules daily for up to a year. Researchers will check tumor size, safety, and quality of life over 6 weeks and beyond.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
HealthPartners Cancer Center at Regions Hospital
RECRUITINGSaint Paul, Minnesota, 55101, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HealthPartners Frauenshuh Cancer Research Center
RECRUITINGSaint Louis Park, Minnesota, 55426, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.